ZIVO Bioscience, Inc. (ZIVOW) Comparison with companies in other sectors?

ZIVO Bioscience, Inc. has a share price of 3.59M. You can analyze ZIVO Bioscience, Inc. (ZIVOW) competitors across different market sectors through stock heatmaps.

What are ZIVOW's NET and operating margins?

ZIVO Bioscience, Inc. (ZIVOW) operating margin is around -134.11, and net profit margin is approximately -134.30 as of the latest reports.

In what way does ZIVOW's earnings per share (EPS) trend reflect its financial momentum?

ZIVO Bioscience, Inc. (ZIVOW) EPS is N/A (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for ZIVO Bioscience, Inc. is N/A, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for ZIVO Bioscience, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for ZIVO Bioscience, Inc. like P/E which is -2.54, P/B which is -25.62, and PEG which is 0.17. Compare them with sector averages to evaluate if the stock is priced fairly.

ZIVO Bioscience, Inc.

ZIVOW•NASDAQ

Healthcare

Biotechnology

$0.18

$-0.23(-56.52%)

Fundamental Analysis of ZIVO Bioscience, Inc. (ZIVOW)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

P/E Ratio

ROE

10.02%

Net Margin

-134.30%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$646.01K

Shares OutstandingTotal number of shares issued

$3.59M

Book Value/ShareNet worth per share

$0.27

Revenue/ShareAnnual revenue per share

$0.03

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

Net MarginNet income as percentage of revenue

-13430.07%

Operating MarginOperating income as percentage of revenue

-13411.40%

ROEReturn on shareholders' equity

1002.48%

ROAReturn on total assets

-1225.65%

ROCEReturn on capital employed

1271.68%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-1.08

Cash/ShareCash and equivalents per share

$0.14

FCF YieldFree cash flow as percentage of market cap

-9.60%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for ZIVOWFinancial Ratios Analysis details for ZIVOW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for ZIVOWSector Benchmarking details for ZIVOW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for ZIVO Bioscience, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of ZIVO Bioscience, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account ZIVO Bioscience, Inc.'s unique business strengths and challenges.

Key Financial Metrics for ZIVO Bioscience, Inc.

For ZIVO Bioscience, Inc., essential financial indicators include EPS -, PE -, and ROE 10.02. These key ratios reveal insights into ZIVO Bioscience, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare ZIVO Bioscience, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of ZIVO Bioscience, Inc.

Metrics like Net Margin -13430.07% and ROA -1225.65% shed light on how well ZIVO Bioscience, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether ZIVO Bioscience, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of ZIVO Bioscience, Inc.

Using ratios such as P/B Ratio -25.62 and PEG Ratio 0.17, investors can assess whether ZIVO Bioscience, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with ZIVO Bioscience, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for ZIVO Bioscience, Inc.

Financial health indicators, such as Debt/Equity Ratio -0.55 and Cash Flow $-1.08, provide a snapshot of ZIVO Bioscience, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like ZIVO Bioscience, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for ZIVO Bioscience, Inc.

Investing in ZIVO Bioscience, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at ZIVO Bioscience, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;